Thomas A. Abrams

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial”.

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-022-02181-8

N/A

4.9DataRank · unranked

192 citations

Jonathan Chen, Sherry Chao, Karin Pelka, Marios Giannakis, Julian M. Hess +40 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0.840DataRank · unranked

30 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1669

N/A

0.705DataRank · unranked

109 citations

Srivatsan Raghavan, Qibiao Wu, Yvonne Y. Li, Liam F. Spurr, Hersh Gupta +35 more

Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-51271-3

N/A

0.654DataRank · unranked

17 citations

Kristen E. Lowder, Kevin S. Kapner, Ronan J. Kelly, Hui Zheng, Nadine J. McCleary +20 more

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1444

N/A

0.505DataRank · unranked

28 citations

Patrick J. Lenehan, Victoire Cardot‐Ruffino, Andressa Dias Costa, Matthew H. G. Katz, Todd W. Bauer +16 more

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2005

N/A

0.503DataRank · unranked

14 citations

Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal +23 more

Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study

BMJ Open Sport & Exercise Medicine(2022)10.1136/bmjsem-2022-001353

N/A

0.434DataRank · unranked

8 citations

Elizabeth Brighton, Nancy Campbell, Nadine J. McCleary, Thomas A. Abrams, James M. Cleary +7 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0.396DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

The Oncologist(2023)10.1093/oncolo/oyad002

N/A

0.369DataRank · unranked

7 citations

Anna M. Chiarella, James M. Cleary, Nora Horick, Colin D. Weekes, Thomas A. Abrams +21 more

Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Digestive Diseases and Sciences(2021)10.1007/s10620-021-07156-2

N/A

0.332DataRank · unranked

5 citations

Andrea J. Bullock, Thomas A. Abrams, Salomão Faintuch, David C. Alsop, S. Nahum Goldberg +3 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092

N/A

0.208DataRank · unranked

3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more

Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.51665

N/A

0.208DataRank · unranked

3 citations

Angela C. Tramontano, Franklin Iheanacho, Thomas A. Abrams, Christopher R. Manz, Kelsey S. Lau-Min

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030

Journal of Hepatocellular Carcinoma(2025)10.2147/jhc.s528033

N/A

0DataRank · unranked

0 citations

Thomas A. Abrams, Andrea Bullock, Alyson Kaplan, Leslie Salas Karnes, Mark Kennedy +8 more

Data from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

(2023)10.1158/1940-6207.c.6547643.v1

N/A

0DataRank · unranked

0 citations

Sui Zhang, Jennifer A. Ligibel, MELINDA L. IRWIN, Lee W. Jones, Nancy Campbell +14 more